IHM
AERI

Iguana Healthcare Management’s Aerie Pharmaceuticals AERI Stock Holding History

Iguana Healthcare Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-130,000
Closed -$4.91M – 82
2016
Q3 		$4.91M Buy
+130,000
New +$2.87M 0.87% 42

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Iguana Healthcare Management's AERI Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2018, closing a stake of 85,000 shares — an estimated $5.08M sold.

Iguana Healthcare Management first reported a position in AERI in Q4 2013 and held it in 15 quarters. The position peaked at $12.5M in Q3 2016. 172 funds tracked by Wall St. Rank hold AERI as of Q1 2018.

  • Iguana Healthcare Management reported no remaining Aerie Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Iguana Healthcare Management sold 85,000 Aerie Pharmaceuticals shares in Q1 2018, an estimated $5.08M.
  • Iguana Healthcare Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 15 quarters.
  • Iguana Healthcare Management's Aerie Pharmaceuticals position peaked at $12.5M in Q3 2016.
  • 172 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.